Clinical Trial Update: Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two doses of Asacol for moderately active ulcerative colitis assessed safety and efficacy; the study is completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Asacol (mesalamine)

Snippet

Sponsor: Warner Chilcott | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2011-07-28